0256.KLSE UMediC Group Berhad
- Market cap
- MYR 103M
- P/E
- 13.7x
- P/B
- 1.16x
- ROE
- 8.9%
- Dividend yield
- 1.09%
- Fundamental score
- 2.5/5
Ratios use the latest price and the fiscal year ending Jul 2026.
Is 0256.KLSE undervalued?
Graham number0256.KLSE trades 15.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
UMediC Group Berhad fundamental analysis
12 of 22 checks passedROE 0/2
Low return on equity (8.9%), below 10%.
ROA 1/1
Return on assets (7.1%) is above the industry median (1.3%).
Profit Consistency 2/2
Profitable for 7 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Last year's EPS growth (-5.1%) is not above the 5-year average (8.7% a year).
Earnings Growth vs Industry 0/1
Last year's EPS growth (-5.1%) is below the industry median (-0.5%).
Revenue Growth 1/2
Revenue grew 8.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (3.7%), 40% or less.
Debt Trend 1/1
Debt to equity has not risen over the past 5 years.
Debt Coverage 0/1
Operating cash flow does not cover 20% of total debt.
Interest Coverage 1/1
EBIT is 40.0x against interest expense, well covered.
PE vs Market 0/1
PE (13.8x) is above the market median (11.4x).
PE vs Industry 1/1
PE (13.8x) is below the industry median (16.1x).
PBV 0/1
Price to book (1.2x) is above the industry median (0.6x).
Graham Number 1/1
The price is below the Graham number (PE x PB = 16.0, limit 22.5).
PEG 0/1
PEG on 5-year earnings growth is 1.58, above 1.
Dividend Yield 0/2
Dividend yield (1.1%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 1/1
Payout ratio is 14.5%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also provides HYDROX prefilled humidifiers and nebulizers; AIRDROX i…
Full company profileUMediC Group Berhad financial statements
UMediC Group Berhad annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | - | 23.7M | 34.1M | 50.7M | 45.4M | 54.6M | 48.6M | 58.7M |
| Gross Profit | - | 7.43M | 12.6M | 18.7M | 18.9M | 22.7M | 22.4M | 25.0M |
| Operating Income | - | 2.79M | 6.68M | 8.63M | 11.3M | 11.2M | 9.47M | 8.93M |
| EBITDA | - | - | - | - | 15.3M | 15.2M | 13.9M | 14.2M |
| Net Income | - | 2.42M | 5.09M | 6.43M | 10.3M | 8.99M | 8.13M | 7.72M |
| EPS | - | 0.01 | 0.01 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 |
| Balance Sheet | ||||||||
| Total Assets | - | 29.9M | 49.9M | 68.9M | 73.3M | 82.7M | 91.2M | 109M |
| Total Liabilities | - | 23.2M | 34.2M | 16.2M | 9.82M | 9.93M | 9.87M | 20.7M |
| Shareholders' Equity | - | 6.63M | 15.7M | 52.7M | 63.0M | 72.0M | 80.1M | 86.7M |
| Cash & Short-term Investments | - | 3.50M | 2.76M | 4.16M | 6.11M | 4.23M | 11.6M | 9.26M |
| Cash Flow | ||||||||
| Operating Cash Flow | - | -3.91M | 3.65M | 8.48M | 1.80M | 4.32M | 11.2M | -6.81M |
| Capital Expenditure | 0.00 | 1.15M | 9.35M | 1.01M | 5.31M | 6.31M | 8.04M | 9.83M |
| Free Cash Flow | - | -5.06M | -5.70M | 7.47M | -3.51M | -1.98M | 3.14M | -16.6M |
| Ratios | ||||||||
| ROE | - | 36.5% | 32.3% | 12.2% | 16.4% | 12.5% | 10.2% | 8.9% |
| ROA | - | 8.1% | 10.2% | 9.3% | 14.1% | 10.9% | 8.9% | 7.1% |
| Net Profit Margin | - | 10.2% | 14.9% | 12.7% | 22.7% | 16.5% | 16.7% | 13.1% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
UMediC Group Berhad dividends
- Dividend yield
- 1.09%
- Forward dividend
- 0.01 MYR
- Payout ratio
- 14.5%
- Ex-dividend date
- Jan 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | MYR 1.12M | 0.00 | 14.5% |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | MYR 1.27M | 0.00 | 52.3% |
| 2019 | MYR 300K | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns UMediC Group Berhad
- Insiders 75.32%
- Institutions 3.03%
- Public & others 21.65%
- Shares outstanding 374M
- Free float 104M
UMediC Group Berhad company profile
- Company name
- UMediC Group Berhad
- Ticker
- 0256.KLSE
- ISIN
- MYQ0256OO006
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 166
- Fiscal year end
- July
- Address
- PMT 790, Jalan Cassia Selatan 5/2, Penang, Malaysia, 14110
- Phone
- 60 4 589 9676
- Website
- umedic.com.my
About UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales services. It also provides HYDROX prefilled humidifiers and nebulizers; AIRDROX inhaler spacers; FLEXIDROX water for inhalation bag; and hospital furniture, life-support solution, MR compatible monitoring solution, oxygen therapy and suction solution, patient monitoring system, resuscitation care, ultrasound solution, women and childcare, critical care solution, and anaesthesia solution. In addition, the company offers various services, including clinical training on equipment, planned preventive maintenance, installations, equipment pre-checks, equipment servicing and repair, 24/7 emergency call-out, unlimited break down call, and spare parts procurement. The company was formerly known as UMediC Group Sdn Bhd and changed its name to UMediC Group Berhad in September 2021. UMediC Group Berhad was incorporated in 2021 and is headquartered in Penang, Malaysia. UMediC Group Berhad is a subsidiary of UMediC Capital Sdn Bhd.
UMediC Group Berhad management
3- Mr. Taw Seong LimCEO & Executive Director · born 1979
- Ms. Hui Hooi NgFinancial Controller · born 1976
- Ms. Yoong Yoong Ooi MAICSACompany Secretary